Skip to main content

Table 1 Relationship between intratumoral PCSK9 expression and clinicopathological features of HCC patients

From: PCSK9 promotes tumor growth by inhibiting tumor cell apoptosis in hepatocellular carcinoma

Variable

PCSK9 expression

p

Low

High

Age (years)

 ≤ 50

23

14

0.851

 > 50

41

27

 

Gender

 Female

10

5

0.624

 Male

54

36

 

AFP (ng/ml)

 ≤ 20

25

19

0.461

 > 20

39

22

 

Number of tumors

 Single

44

28

0.961

 Multiple

20

13

 

Tumor size (cm)

 ≤ 5

43

14

0.001

 > 5

21

27

 

Tumor cell differentiation

 I–II

45

30

0.752

 III–IV

19

11

 

Microvascular invasion

 No

32

12

0.036

 Yes

32

29